BRIEF-Tesaro announces submission of investigational new drug application

* Tesaro Announces Submission Of Investigational New Drug Application For Anti Tim-3 antibody tsr-022 to the u.s. Fda
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.